Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Amodiaquine for Uncomplicated Falciparum Malaria in Children
NCT00261222Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of amodiaquine in Malaria, sponsored by Heidelberg University. Primary endpoint: Total clinical failure rate at 14 days. Started Sep 2005; status: completed.
02
Drugs
amodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00261222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261222.